Acetylsalicylsyre, ACE- hæmmere, beta- blokkere, svage CYP3A4 - inhibitorer, diuretika og lægemidler til behandling af diabetes (sulfonylurinstoffer og metformin).
Although specific interaction studies were not conducted for all medicinal products, population pharmacokinetic analysis showed no effect on vardenafil pharmacokinetics of the following concomitant medicinal products: acetylsalicylic acid, ACE-inhibitors, beta-blockers, weak CYP 3A4 inhibitors, diuretics and medicinal products for the treatment of diabetes (sulfonylureas and metformin).